Literature DB >> 14587296

Caspase activation.

Kelly M Boatright1, Guy S Salvesen.   

Abstract

Caspase activation is the 'point of no return' commitment to cell death. Synthesized as inactive zymogens, it is essential that the caspases remain inactive until the death signal is received. It is known for the downstream executioner caspases-3 and -7 that the activation event is proteolytic cleavage, and this had been assumed to apply to the initiator caspases as well. However, recent studies conducted on caspases-2, -8 and -9 have challenged this tenet of caspase activation. In this review we focus on the molecular details of caspase activation, with emphasis on recent work that provides a pleasing explanation for the differential requirements for the activation of executioner and initiator caspases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587296     DOI: 10.1042/bss0700233

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  24 in total

1.  A Large-scale genetic association study of esophageal adenocarcinoma risk.

Authors:  Chen-Yu Liu; Michael C Wu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Rihong Zhai; Zhaoxi Wang; Li Su; Rebecca S Heist; Matthew H Kulke; Xihong Lin; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2010-05-07       Impact factor: 4.944

2.  ProMoST (Protein Modification Screening Tool): a web-based tool for mapping protein modifications on two-dimensional gels.

Authors:  Brian D Halligan; Victor Ruotti; Weihong Jin; Scott Laffoon; Simon N Twigger; Edward A Dratz
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.

Authors:  Sivapriya Ponnurangam; Joshua M V Mammen; Satish Ramalingam; Zhiyun He; Youcheng Zhang; Shahid Umar; Dharmalingam Subramaniam; Shrikant Anant
Journal:  Mol Cancer Ther       Date:  2012-02-08       Impact factor: 6.261

4.  Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.

Authors:  Santiago Pérez-Rodríguez; Maria A Ortiz; Raquel Pereira; Fátima Rodríguez-Barrios; Angel R de Lera; F Javier Piedrafita
Journal:  Eur J Med Chem       Date:  2009-01-20       Impact factor: 6.514

5.  A PI3K pathway mediates hair cell survival and opposes gentamicin toxicity in neonatal rat organ of Corti.

Authors:  Won-Ho Chung; Kwang Pak; Bo Lin; Nicholas Webster; Allen F Ryan
Journal:  J Assoc Res Otolaryngol       Date:  2006-10-20

6.  Oridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cells.

Authors:  Zhe Ji; Qingjiu Tang; Jinsong Zhang; Yan Yang; Yanfang Liu; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

7.  Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening.

Authors:  Ruili Huang; Noel Southall; Ming-Hsuang Cho; Menghang Xia; James Inglese; Christopher P Austin
Journal:  Chem Res Toxicol       Date:  2008-02-19       Impact factor: 3.739

8.  Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases.

Authors:  Sabine Kersting; Matthias Bruewer; Guido Schuermann; Axel Klotz; Markus Utech; Matthias Hansmerten; Christian F Krieglstein; Norbert Senninger; Joerg-Dieter Schulzke; Hassan Y Naim; Klaus-Peter Zimmer
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway.

Authors:  Sanchita Rauth; Sudipta Ray; Sayantan Bhattacharyya; Debapriya Ghosh Mehrotra; Neyaz Alam; Goutam Mondal; Partha Nath; Asoke Roy; Jaydip Biswas; Nabendu Murmu
Journal:  Mol Cell Biochem       Date:  2016-05-20       Impact factor: 3.396

10.  Febrile-range hyperthermia accelerates caspase-dependent apoptosis in human neutrophils.

Authors:  Ashish Nagarsekar; Rachel S Greenberg; Nirav G Shah; Ishwar S Singh; Jeffrey D Hasday
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.